HOME >> BIOLOGY >> NEWS
Unique international conference to focus on effectiveness, safety of medicinal herbs

By David Williamson
UNC-CH News Services

CHAPEL HILL -- Are medicinal herbs -- now extremely popular in the United States and abroad but only poorly regulated -- safe? Do they really work? How much should a person take in hope of producing the desired effect? Those are the chief questions top researchers will try to answer March 2-3 as the University of North Carolina at Chapel Hill hosts the first international scientific conference on "The Efficacy and Safety of Medicinal Herbs."

Speakers from Canada, England, Germany and the United States will discuss what's been confirmed about eight of the world's most widely used herbs at the university's Friday Center, according to conference co-chair Dr. Lenore Arab. Those herbs are garlic, ginseng, ginko biloba, comfrey, saw palmetto, feverfew, echinacea and St. John's wort.

"It's essential that health professionals know what we know about these products and what's still speculation so that they can give informed advice," said Arab, professor of epidemiology and nutrition at the UNC-CH schools of medicine and public health. "Right now, the public has stopped asking, and even if they were, most health professionals do not feel that they are in a position to give advice.

"As a result, the train is running wild down the track. People are self-medicating without any guidance. They might be taking extremely high, possibly dangerous, doses because they think more is better, or they may be getting so little that they're simply wasting their money."

As an example, she cited comfrey, which can cause liver damage and even liver failure. Banned in Canada and Europe, the herb is still widely available in U.S. health food stores.

Some 400 scientists, nutritionists and others are expected to attend the conference, Arab said.

Dr. Varro Tyler, professor and dean emeritus of pharmacy at Purdue University, will give the keynote address, "Herbal Medicine: From the
'"/>

Contact: David Williamson
David_Williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
13-Jan-2000


Page: 1 2

Related biology news :

1. Unique partnership between UH, FDA opens path for scientific exchange
2. Unique two-part macroemulsion offers new approach to cleaning up contaminated aquifers
3. Unique fleet of underwater vehicles to gather elusive environmental data
4. Unique feeding behavior discovered for snakes
5. Unique population of muscle stem cells found in mice
6. Unique social system found in famous Tsavo lions
7. Unique national park for orchids to be declared in Africa
8. Unique genetic alteration in presenilin 1 gene predisposes some Caribbean Hispanics to early-onset Alzheimers disease
9. Unique UNC study confirms suspected worldwide epidemic of childhood obesity
10. Scientists find just how discriminating a worm can be: Unique system of overlapping odor sensors discovered
11. Unique study reveals new details on how genes are transcribed

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
Breaking Biology Technology:
Cached News: